Get the Stockscreener App
189.18
0.36%
0.68
After Hours:
189.12
-0.06
-0.03%
Krystal Biotech Inc Stock (KRYS) Latest News
Analysts Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $220.00 - Defense World
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Raymond James Financial Inc. Takes $15.99 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Is Krystal Biotech, Inc.'s (NASDAQ:KRYS) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Simply Wall St
Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock - Yahoo Finance
US Bancorp DE Grows Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Krystal Biotech CEO Krishnan sells $8.89 million in stock By Investing.com - Investing.com Australia
Krystal Biotech president Suma Krishnan sells $8.9 million in shares By Investing.com - Investing.com Australia
Krystal Biotech president Suma Krishnan sells $8.9 million in shares - Investing.com India
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Keybank National Association OH - Defense World
How to Take Advantage of moves in (KRYS) - Stock Traders Daily
Bank of New York Mellon Corp Has $26.53 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait? - Nasdaq
Krystal Biotech (NASDAQ:KRYS) Earns Buy Rating from Analysts at Jefferies Financial Group - Defense World
Krystal Biotech initiated at buy at Jefferies on Vyjuvek, gene delivery tech - MSN
Krystal Biotech at TD Cowen Conference: Strategic Pipeline Progress By Investing.com - Investing.com Canada
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga India
Krystal Biotech’s Growth Potential: Strong Vyjuvek Launch and Promising Pipeline - TipRanks
Jefferies Initiates Krystal Biotech at Buy With $245 Price Target -March 05, 2025 at 07:22 am EST - Marketscreener.com
Jefferies Initiates Coverage of Krystal Biotech (KRYS) with Buy Recommendation - Nasdaq
Jefferies sets Krystal Biotech stock Buy rating, $245 target By Investing.com - Investing.com Australia
Krystal Biotech initiated with a Buy at Jefferies - TipRanks
Gene Therapy Market Top Companies Study-Krystal Biotech, Inc., - openPR
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Is the Market Bullish or Bearish on Krystal Biotech? - Benzinga
KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug - Yahoo Finance
H.C. Wainwright maintains $221 target on Krystal Biotech stock By Investing.com - Investing.com Canada
H.C. Wainwright maintains $221 target on Krystal Biotech stock - Investing.com India
Krystal Biotech’s (KRYS) “Buy” Rating Reiterated at HC Wainwright - Defense World
New York State Common Retirement Fund Has $3.66 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Principal Financial Group Inc. Purchases 3,727 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal gets positive EU regulatory opinion for Vyjuvek - MSN
Krystal Biotech chief accounting officer sells $131,415 in stock - Investing.com India
Krystal Biotech chief accounting officer sells $131,415 in stock By Investing.com - Investing.com UK
Solid Earnings Reflect Krystal Biotech's (NASDAQ:KRYS) Strength As A Business - Yahoo Finance
(KRYS) On The My Stocks Page - Stock Traders Daily
Krystal gets positive EU regulatory opinion for Vyjuvek (KRYS:NASDAQ) - Seeking Alpha
Krystal Biotech’s Vyjuvek: Anticipated European Approval and Strong Sales Projections Drive Buy Rating - TipRanks
European Panel Backs Approval of Topical Gene Therapy, Three Other New Medicines - Marketscreener.com
Krystal Biotech receives positive CHMP opinion for VYJUVEK - TipRanks
Krystal Biotech Gets CHMP Backing for Vyjuvek Approval - MarketWatch
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa - The Manila Times
Illinois Municipal Retirement Fund Has $2.22 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
C WorldWide Group Holding A S Cuts Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
HC Wainwright Forecasts Krystal Biotech Q1 Earnings - MarketBeat
Chardan Capital Predicts Krystal Biotech FY2026 Earnings - MarketBeat
Krystal Biotech Q1 EPS Estimate Increased by William Blair - MarketBeat
Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Raised by State of New Jersey Common Pension Fund D - Defense World
Principal Financial Group Inc. Boosts Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know - MSN
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Why Krystal Biotech (KRYS) Might be Well Poised for a Surge - MSN
Why Krystal Biotech, Inc. (KRYS) is a Top Momentum Stock for the Long-Term - Nasdaq
Hussman Strategic Advisors Inc. Makes New $658,000 Investment in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Rhumbline Advisers Reduces Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech Earnings Call: Optimism Amid Challenges - TipRanks
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):